MedPath

Study of New Prognostic Factors in Patients Who Received Postoperative Chemotherapy for Endometrial Cancer(JGOG2043-A2)

Not Applicable
Conditions
Endometrial cancer
Registration Number
JPRN-UMIN000036755
Lead Sponsor
Japanese Gynecologic Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
718
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We analyzed new prognostic factors in patients who received postoperative chemotherapy for endometrial cancer (patients enrolled in the JGOG2043 study) to investigate an effective classification for clinical practice and new stratification factors for clinical studies.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath